Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131841) titled 'A Single-Center Clinical Study of Romiplostim N01 for Injection in the Thrombocytopenia Induced by Neoadjuvant Chemotherapy for Gastric Cancer' on Sept. 7.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Sichuan Cancer Hospital
Condition:
Gastric cancer, diagnosed by pathology or cytology, including cancers of the non-esophageal segment and the esophageal segment, is classified as locally advanced gastric cancer. Specific staging includes: non-esophageal segment tumors, cT3-4aN+M0
esophageal segment tumors, cT1-2N+M0, cT3-4aN+M0 (AJCC, 8th edition, 2017).
Recruitment Status: Not ...